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Human retrotransposons, Am-family DNA repeats (AFRs), have variable nucleotide sequence but conservative short 
elements, which may have important functions, are also present. In our previous reports we have described human nuclear 
DNA-binding protein interacting with AFRs and evidence was presented that the protein recognizes sequence motif 
S-GGAGGC-3’ which is conserved in the spacer of RNA polymerase III promoter of AFRs and in the SV40 T-antigen- 
dependent replication origin of AFRs. In this study it was found that double-stranded synthetic oligonucleotides contain- 
ing indicated conservative sequences of AFRs actually have high-affinity binding site for HeLa nuclear protein. The data 
suggest that non-infected human cells contain nuclear DNA-binding protein which recognizes the conservative sequence 
motif of AFRs - GGAGGC. 
Alu repeat; Conservative motif; DNA-binding protein 
1. INTRODUCTION 
DNA-binding proteins interacting with conser- 
vative sequence lements of eukaryotic promoters 
play an important role in the up and down regula- 
tion of transcription. Alu-family DNA repeats 
(AFRs) which are human retrotransposons [l-3] 
contain bipartite internal promoter for RNA poly- 
merase III which is active in vitro [4] but is tran- 
scriptionally silent in HeLa cells in vivo [5]. The 
nucleotide sequence of human AFRs is rather 
variable [6] but some conserved elements are also 
present [7]. One of the conservative regions is 
situated at the left end of AFRs covering the enhan- 
cing element of polII1 promoter and a part of 
spacer between enhancing and directing elements 
(fig. 1). 
In our previous reports [8-121 we have described 
human nuclear protein interacting selectively with 
a typical AFR present in the plasmid BLUR8 [13]. 
Differential binding of restriction subfragments of 
BLUR8 ARF [ll], and DNase footprinting ex- 
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periments [12] suggest hat two regions within AFR 
are important for protein binding: (i) a spacer be- 
tween enhancing and directing elements of the 
RNA polymerase III (~01111) promoter, (ii) a cen- 
tral region containing the SV40 T-antigen-binding 
site and the replication origin [14]. Common con- 
servative sequence for these regions is hexamer 
GGAGGC [ 121. To obtain further evidence for the 
specificity of the Am-binding protein, we have us- 
ed in this study two synthetic double-stranded 
oligonucleotides containing the hexamer motif, 
and one cloned oligonucleotide with a double hex- 
amer sequence (table l), as well as synthetic oligo- 
nucleotides (API and AP3) having no common se- 
quences with AFRs. 
2. MATERIALS AND METHODS 
Nuclear 0.4 M NaCl extract from HeLa cells isolated as 
described before [9,10] was used in all experiments of this study 
as a source of Alu-binding protein. The sequences of oligo- 
nucleotides used in this study are shown in table 1. All the oligo- 
nucleotides except T2 were synthesized using Gene Assembler 
(Pharmacia). Oligonucleotide T2 containing the SV40 T- 
antigen-binding site I (table 1) was isolated after cleavage of the 
plasmid pT2 with EcoRI and HindIII. Plasmid pT2, a gift from 
Dr S. Mirkin (Institute of Molecular Genetics AS USSR, 
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Moscow), was constructed by subcloning the double-stranded 
T2 oligonucleotide (table 1) tailored with the BarnHI and EcoRI 
cohesive ends into BarnHI, EcoRI-cleaved plasmid pUC19. A 
58 bp EcoRI-Hind111 fragment from pT2 containing a hexamer 
doublet and a part of pUC 19 polylinker was 3 ‘-end-labeled with 
32P using Klenow DNA polymerase and [cu-‘*P]dATP, and 
purified in a 5% polyacrylamide gel. Non-cloned synthetic 
oligonucleotide AluB4 was 5 ‘-end-labeled using [y-‘*P]ATP 
and polynucleotide kinase. The double-stranded substrate was 
prepared by mixing ‘*P-AluB4 with 3-fold molar excess of non- 
labeled AluB3, heating for 1 min at 90°C and then slowly cool- 
ing to room temperature in aDNA-binding buffer [lo]. Non- 
labeled competitor oligonucleotides were prepared in the same 
way after mixing equimolar amounts of complementary oligo- 
nucleotides. A mobility shift assay and other methods were 
described before [g-12]. 
3. RESULTS AND DISCUSSION 
Working with partially purified preparations of 
Alu-binding protein (40.4 fraction, see [lo]) and 
oligonucleotide T2 (table l), we have detected two 
DNA-protein complexes, Xl and X2 [12], in a 
mobility shift assay and it was suggested that in the 
low mobility complex, X2, both GGAGGC hex- 
amers are bound to protein and in the high mobility 
complex, Xl, only one. To check whether human 
cells contain other proteins interacting with T2, we 
have used a mobility shift assay with this oligo- 
nucleotide, no partially purified Alu-binding pro- 
tein, but a crude nuclear extract from HeLa and 
have observed complexes indistinguishable (fig.2) 
from the Xl and X2 complexes observed with the 
partially purified Alu-binding protein [ 121. The 
data are consistent with the view that human cells 
contain only one major GGAGGC-binding protein 
and that there are no other DNA-binding proteins 
interacting with high affinity with T2 oligo- 
nucleotide. As expected, of the two AT-rich mam- 
malian DNAs used (calf thymus and human 
placenta) human DNA showed the higher com- 
petitor activity (fig.2, lane 3), and the GC-rich 
DNA from Micrococcus luteus (fig.2, lane 2) was a 
better competitor than the DNA from Escherichia 
coli (fig.2, lane 4). 
32P-labeled double-stranded oligonucleotide 
AluB (table 1) containing a single GGAGGC hex- 
amer was incubated with nuclear extract from 
HeLa cells in the presence of a fixed amount 
(100 ng) of calf thymus DNA and different 
amounts of non-labeled competitor oligo- 
nucleotides which were either non-ligated (fig.3A) 
or treated with T4 phage polynucleotide kinase and 
DNA ligase (fig.3B). It is seen from fig.3A that 
AluB oligonucleotide forms a single complex with 
protein, which is stable in the presence of 3-lo-fold 
molar excess of GGAGGC-free oligonucleotide 
APl (fig.3, lanes 1 and 2). The same amount of 
complex was observed in the absence of oligo- 
nucleotides (not shown). However, the addition of 
AluB non-labeled oligonucleotide suppresses the 
Table 1 
Oligonucleotides used in this study 
Name of ds Name of ss Sequence Origin of sequence 
oligonucleotide oligonucleotide 
AluA 
AluA 1 5'-GGAGGCTGAGGCA-3' Alu consensus T-antigen- 
AluA2 3'-CCTCCGACTCCGT-5' binding site 
AluB 
AluB4 5'-TGGGAGGCCAAGGA-3' Alu left end conserved region 
AluB3 3'-ACCCTCCGGTTCCT-5' 
API 
APll 5'-GATCGTGACTCAGCGC -3' transcription factor API site 
AP12 3’- CACTGAGTCGCGCTAG-5' in hMTI1 alpha promoter 
AP3 
AP3 1 5'-GATCTGGGACTTTCCACA -3' SV40 early promoter factor 
AP32 3’- ACCCTGAAAGGTGTCTAG-5' AP3-binding site 
T2a (cloned) 
5’-. . . GGAGGCTTTTTTGGAGGC...-3' SV40 T-antigen-binding site I 
3’-. . . CCTCCGAAAAAACCTCCG...-5' from early region 
a This synthetic oligonucleotide tailored with EarnHI (left) and EcoRI (right) cohesive ends was cloned into BarnHI-EcoRI cleaved 
plJC19 to get pT2. 3’-end-labeled HindIII-EcoRI 58 bp fragment from pT2 was used in the binding experiment (fig.2). Plasmid pT2 
was kindly supplied to us by Dr S. Mirkin (Moscow) 
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Fig. 1. Conservative and variable regions at the left end of Alu repeats. CONS, consensus Alu sequence is taken from [7] and all devia- 
tions from the consensus in 40 ARFs from GenBank are plotted; - , nucleotide deletion. The position of a hot spot of Alu-Alu recom- 
bination is taken from 1151, and of the polII1 promoter from [4]. Note a high degree of variability at methylatable CG sequences of 
the consensus. 
formation of the complex under the conditions 
used (fig.3, lanes 3 and 4). Similar but lower in- 
hibiting effect showed non-labeled oligonucleotide 
AluA (fig.3, lane 6) which also contains GGAGGC 
(table 1). The same result was obtained with the 
ligated competitor oligonucleotides (fig.3B). In this 
experiment a longer incubation time was used 
which resulted in a decrease of the apparent com- 
petitor activity as compared to the experiment 
shown in fig.3A. The protein-binding site clearly 
present in AluA seems to have an affinity 2-3 times 
lower to protein than the site present in AluB, 
which was estimated from the relative concentra- 
tion of competitor oligonucleotides leading to 50% 
binding inhibition. Again, GGAGGC-free oligo- 
nucleotide AP3 showed a much lower affinity to 
the GGAGGC-binding protein as compared to 
AluA and AluB (fig.3B). 
We examined the binding inhibition of AluB by 
some non-labeled genomic DNAs (fig.4) and found 
that human DNA is about 3-times better a com- 
petitor than calf thymus or E. coli DNA, consistent 
with the view that the density of GGAGGC- 
binding sites in human DNA is higher than in other 
DNAs. In a random DNA sequence any definite 
hexamer is present on average once in 4 kb of DNA 
but human DNA contains additional GGAGGC 
sites which are conserved in Alu-repeats. 
The results presented in this paper as well as 
those published before [ 11,121 strongly suggest that 
human cells contain high-affinity DNA-binding 
protein which recognizes the sequence 5 ‘-GGA- 
GGC-3 ’ conserved in the spacer region of the RNA 
polymerase III promoter of the Alu-family DNA 
repeats as well as in the T-antigen-dependent origin 
of replication of the repeats (fig. 1 and [7]). The ex- 
istence of such a protein anticipates the importance 
of the GGAGGC motif in the life cycle of the 
retrotransposon. Although other explanations are 
apparently possible, we would like to suggest he 
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Fig.2. Gel retention pattern after binding of T2 oligonucleotide. 
“P-labeled T2 oligonucleotide (0.5 ng) was incubated for 
30 min at room temperature with 1 pl of HeLa nuclear extract 
and 100 ng of calf thymus DNA (lane I), M. luteus DNA (lane 
2), human placental DNA (lane 3) and E. coli DNA (lane 4) in 
the binding buffer [lo], runned in a 4% polyacrylamide gel, 
then gel was dried and radioautographed, F free fragment; Xl 
and X2, complexes with protein. 
hypothesis that the human GGAGGC-binding pro- 
tein might be a repressor of RNA polymerase III- 
driven transcription of Alu-repeats, since binding 
sites for the protein are situated in the polII1 pro- 
moter, and since AFRs are transcriptionally silent 
in HeLa cells in vivo [5] where the protein is pre- 
sent. The complexes of the GGAGGC-binding pro- 
tein and Alu-repeats might be stabilised by 
cooperative binding at the two indicated hexamer 
sites [l l] which are separated by 12.9 helical turns 
and may bind a single dimer of protein [ 11,171. 
Interestingly, the left part of the spacer between 
enhancing and directing elements of ~01111 pro- 
moter (fig.1) is a hot spot of Alu-Alu recombina- 
tion [ 151 which might be an indirect consequence of 
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Fig.3. The inhibition of the binding of “P-labeled AluB oligo- 
nucleotide by different non-labeled oligonucleotides. 0.12 ng of 
32P-labeled AluB (table 1) was incubated for 10 min (A) or 
30 min (B) at room temperature with 1 /cl of HeLa nuclear ex- 
tract in the presence of 100 ng of non-labeled calf thymus DNA 
and of different amounts of competitor oligonucleotides either 
non-ligated (A) or treated with T4 polynucleotide kinase and 
DNA ligase (B). In A, lanes 1 and 2 show the influence of 3- and 
IO-fold molar excesses of API (no inhibition of binding), lanes 
3 and 4, 3- and IO-fold excesses of AluB, lanes 5 and 6, 3- and 
lo-fold molar excesses of AluA. F, free oligonucleotide; B, 
complexes. For other methods see legend to fig.2. 
nucleotide sequence conservation in this region, 
since non-homologous recombination in non- 
conserved regions of Alu-repeats should be sup- 
pressed in somatic cells [ 161. 
Volume 25 1, number 1,2 FEBS LETTERS July 1989 
CALF TRYWS 
\ 
E.COLI 
i, 
I I I 
200 400 800 1600 
QUANTITY OF NON-LABELED COUPETPCR 
DNA (ng) 
Fig.4. Competition of different non-labeled genomic DNAs for 
the binding of labeled AluB oligonucleotide. For methods see 
legend to fig.3. (0) Competitor DNA from human placenta, 
(0) DNA from calf thymus, (*) DNA from E. co/i. The 
amount of complex (measured by densitometry of radio- 
autograph) at 200 ng of a given competitor DNA is taken as 
100%. 
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